.png?token=69e69e932234d495e0ff261ba92abf9e)
A Smart Drug Delivery Platform
Peptinovo’s novel peptide-based delivery platform, uses cancer’s growth pathway to safely carry stronger doses of proven drugs directly into tumors while keeping them away from healthy tissue.
Peptinovo’s novel peptide-based delivery platform, uses cancer’s growth pathway to safely carry stronger doses of proven drugs directly into tumors while keeping them away from healthy tissue.
We are currently completing pre-IND enabling testing on our first drug, PNB-281 (our PALM™ carrier with the industry-leading chemotherapy paclitaxel). Three additional chemotherapy drugs have been developed and are ready to enter pre-IND.
Peptinovo’s seasoned team has launched three drugs from idea to market, started seven individual pharma companies, and led all aspects needed to develop, test, and launch pharmacology products.